Search PubMed⌕ Search

Biomedical subjects

M Livingston

Publications and source records attributed to M Livingston.

At least 37 records · Page 2Linked to original sources
PubMed1996

Having a future: sexual decision making in early adolescence.

There is meager information about how adolescents decide to become sexually active and use protection against pregnancy and disease. The purpose of this project was to explore the thinking of adolescents, ages 12 to 14, about becoming sexually active and using protection during sexual encounters. In a health class, 45 adolescents responded to questions about influences on having sex and using protection. Short-answer, written responses were analyzed using Heideggerian hermeneutic interpretation. The reflections of youth faced with sexual decision-making focused on self-protection against pregnancy and disease. Postponing sexuality or using protection meant having a future, one that could hold the promise of love, marriage, and desired children.

Adolescent↗
PubMed1993

Whiplash injury and peer copying.

Whiplash injury has increased during the past 40 years. Peer copying has occurred both among patients and practitioners. The importance of understanding the common course of the injury is stressed and simpler and less costly management suggested. Also noted is the importance of digesting whole articles. Reliance upon abstracted material alone or parts of articles may prove to be misleading and may lead to perpetuating questionable information.

Abstracting and Indexing↗
PubMed1992

Whiplash injury: misconceptions and remedies.

Misconceptions about whiplash injury and its common course are discussed. Different patient populations appear to suffer to varying degrees and social copying is evident in certain groups--features shared with the Australian 1983 to 1985 'epidemic' of 'repetitive strain syndrome'. Psychosocial factors and overtreatment delay recovery. Family physicians have the opportunity to properly assess and manage most patients. Wasteful therapy must be discouraged, and self care and patient responsibility encouraged.

Causality↗
PubMed1990

Affective flattening in elderly patients.

Forty-eight consecutive patients not taking dopamine antagonists and without Parkinson's disease referred to a psychogeriatric service with a diagnosis of psychiatric disorder were assessed for affective flattening using an objective rating scale. Nearly half (44%) exhibited significant affective flattening, which proved open to reliable assessment. Affective flattening is a useful sign of pathology.

Affect↗
PubMed1990

A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.

Sixty-one patients with acute schizophrenia received either remoxipride (75-375 mg daily) or thioridazine (150-750 mg daily) for 6 weeks. There was no statistically significant between-drug difference in improvement in mental state, as measured by the Brief Psychiatric Rating Scale, although the trend favoured thioridazine; global assessment of illness severity at the last rating also favoured thioridazine. Sedation, anticholinergic effects, autonomic dysfunction, and weight gain were significantly more common in patients receiving thioridazine. Both drugs produced few extrapyramidal effects, but both were associated with cardiovascular changes in two patients; neither drug produced significant abnormalities in laboratory tests.

Acute Disease↗
PubMed1989

Maintaining remission in mood disorders.

The natural history of bipolar and unipolar affective disorders is for increasing severity and frequency of attacks as the patient ages. A major challenge for clinicians is the initiation and maintenance of prophylaxis.

Antidepressive Agents, Tricyclic↗
PubMed1989

Treatment of acute major mood disturbance.

Depression is a common presentation in family practice, and together with mania, constitutes the group of psychiatric disorders known as major mood disturbance. There are many ways to approach these problems from classification to management. Drug treatment is thought to be more successful in the presence of biological symptoms, and the GP should be familiar with one or two drugs from each group for best effect.

Acute Disease↗
PubMed1989

Management of chronic schizophrenia.

Schizophrenia is usually a chronic illness characterised by a series of relapses. Long-term management aims to achieve symptomatic remission for as long as possible. Maintenance drug therapy should be considered and is about one-third of the acute dose. Support in the community as offered by multi-disciplinary teams at day centres and community organisations plays an important part.

Antipsychotic Agents↗